Roche
RO.SW
#41
Rank
NZ$563.79 B
Marketcap
NZ$708.63
Share price
-0.06%
Change (1 day)
35.04%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$34.39

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$34.39. In 2025 the company made an earnings per share (EPS) of NZ$34.39 an increase over its 2024 EPS that were of NZ$19.36.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$34.3977.67%
2024NZ$19.36-32.84%
2023NZ$28.821.95%
2022NZ$28.27-6.29%
2021NZ$30.17-5.53%
2020NZ$31.9316.56%
2019NZ$27.4030.3%
2018NZ$21.0320.22%
2017NZ$17.49-5.81%
2016NZ$18.574.62%
2015NZ$17.75-5.13%
2014NZ$18.71-25.05%
2013NZ$24.9621.73%
2012NZ$20.503.82%
2011NZ$19.758.16%
2010NZ$18.2623.72%
2009NZ$14.76-12.31%
2008NZ$16.83-0.34%
2007NZ$16.8932.13%
2006NZ$12.7842.56%
2005NZ$8.96-22.7%
2004NZ$11.60132.85%
2003NZ$4.98-148.05%
2002NZ-$10.36-209.09%
2001NZ$9.50-57.03%
2000NZ$22.1153.29%
1999NZ$14.4231.24%
1998NZ$10.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.70-57.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.81-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.20-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.07-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.37-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.31-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.19-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$5.99-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.54-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK